Sounak Gupta, M.B.B.S., Ph.D., explains how Mayo Clinic Laboratories' gynecological NGS panels provide focused assessments of gynecological cancers. The cost-effective tests fill the gap between single gene assays and large cancer panels,...
Mayo Clinic Laboratories and Progentec launch lupus advanced biomarker testing services - Insights
As a successful outcome of the collaboration announced in 2023, Progentec’s proprietary biomarker blood tests for the proactive management of systemic lupus erythematosus are now available through Mayo Clinic Laboratories.
Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D. - Insights
Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing.
Meet Me at the Microscope at USCAP 2020 - Insights
Mayo Clinic pathologists, researchers, and a wide spectrum of allied health staff will be in Los Angeles, California, for the 109th United States and Canadian Academy of Pathology Meeting (USCAP). Visit us at booth #716 on March 2 - 4, 2020...
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 24 - Insights
This week’s Research Roundup highlights the limitations of platform assays to measure serum 25OHD level impact on guidelines and practice decision-making.
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 22 - Insights
This week’s Research Roundup highlights neoantigenic potential of complex chromosomal rearrangements in mesothelioma.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 18 - Insights
This week’s Research Roundup highlights Mayo Clinic researchers who conducted a study to characterize the clinical, pathologic, and survival implications of non-V600 BRAF mutations in metastatic colorectal cancer.
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 16 - Insights
This week’s Research Roundup highlights the role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy.
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.